Literature DB >> 6138541

Monoclonal antibodies protect against respiratory syncytial virus.

G Taylor, E J Stott, M Bew, B F Fernie, P J Cote.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6138541     DOI： 10.1016/s0140-6736(83)90499-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

Review 1.  The respiratory syncitial virus and its role in acute bronchiolitis.

Authors:  M L Everard; A D Milner
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

2.  An Epitope-Specific Respiratory Syncytial Virus Vaccine Based on an Antibody Scaffold.

Authors:  Xiaozhou Luo; Tao Liu; Ying Wang; Haiqun Jia; Yuhan Zhang; Dawna Caballero; Juanjuan Du; Rongsheng E Wang; Danling Wang; Peter G Schultz; Feng Wang
Journal:  Angew Chem Int Ed Engl       Date:  2015-10-05       Impact factor: 15.336

Review 3.  Monoclonal antibodies against microorganisms.

Authors:  R A Polin
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

Review 4.  Respiratory syncytial virus. Brief review.

Authors:  E J Stott; G Taylor
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

5.  A comparison of three vaccines against respiratory syncytial virus in calves.

Authors:  E J Stott; L H Thomas; G Taylor; A P Collins; J Jebbett; S Crouch
Journal:  J Hyg (Lond)       Date:  1984-10

Review 6.  Respiratory syncytial virus vaccine development.

Authors:  Yoshihiko Murata
Journal:  Clin Lab Med       Date:  2009-12       Impact factor: 1.935

7.  IgG and IgM antibodies to viral glycoproteins in respiratory syncytial virus infections of graded severity.

Authors:  G L Toms; M S Webb; P D Milner; A D Milner; E G Routledge; R Scott; G M Stokes; A Swarbrick; C E Taylor
Journal:  Arch Dis Child       Date:  1989-12       Impact factor: 3.791
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.